sshepard/iStock Unreleased via Getty Images
Vaccine makers targeting COVID-19 to measles will come under investor scrutiny on Tuesday as a group of independent experts at the CDC are scheduled to meet for the first time to review U.S. immunization guidelines under Robert F. Kennedy Jr., a well-known vaccine